Nanalysis Scientific Corp.
NSCIF
$0.11
$0.0112.66%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.60% | -2.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.60% | -2.60% | |||
| Cost of Revenue | 5.96% | 0.52% | |||
| Gross Profit | 40.92% | -12.34% | |||
| SG&A Expenses | -13.07% | -24.67% | |||
| Depreciation & Amortization | -39.05% | -15.53% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.08% | -7.99% | |||
| Operating Income | 126.30% | 36.05% | |||
| Income Before Tax | 50.40% | 30.86% | |||
| Income Tax Expenses | -199.14% | 147.15% | |||
| Earnings from Continuing Operations | 51.99% | 28.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.99% | 28.99% | |||
| EBIT | 126.30% | 36.05% | |||
| EBITDA | 144.16% | 36.66% | |||
| EPS Basic | 52.63% | 29.63% | |||
| Normalized Basic EPS | 48.21% | 35.63% | |||
| EPS Diluted | 24.21% | 34.48% | |||
| Normalized Diluted EPS | 48.21% | 35.63% | |||
| Average Basic Shares Outstanding | 2.09% | 1.13% | |||
| Average Diluted Shares Outstanding | 2.09% | 1.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||